Phibro Animal Health Files 2024 10-K

TL;DR

PHIBRO filed its 2024 10-K. Full year results are in. Check it out.

AI Summary

Phibro Animal Health Corporation filed its 10-K for the fiscal year ending June 30, 2024. The company, headquartered in Teaneck, NJ, reported its financial performance and business operations. Key financial details and strategic initiatives are outlined in the filing, which provides a comprehensive overview of the company's status as of August 28, 2024.

Why It Matters

This filing provides investors and stakeholders with a detailed look at Phibro Animal Health's financial health and operational performance for the past fiscal year, influencing investment decisions.

Risk Assessment

Risk Level: medium — The filing is a standard annual report and does not inherently indicate new or elevated risks.

Key Players & Entities

• PHIBRO ANIMAL HEALTH CORP (company) — Filer
• 20240630 (date) — Fiscal Year End
• 20240828 (date) — Filing Date
• Teaneck, NJ (location) — Company Headquarters

FAQ

Filing Documents

• pahc-20240630x10k.htm (10-K) — 4453KB
• pahc-20240630xex2d1.htm (EX-2.1) — 1041KB
• pahc-20240630xex10d1.htm (EX-10.1) — 216KB
• pahc-20240630xex10d25.htm (EX-10.25) — 58KB
• pahc-20240630xex19d1.htm (EX-19.1) — 43KB
• pahc-20240630xex21d1.htm (EX-21.1) — 34KB
• pahc-20240630xex23d1.htm (EX-23.1) — 2KB
• pahc-20240630xex31d1.htm (EX-31.1) — 11KB
• pahc-20240630xex31d2.htm (EX-31.2) — 11KB
• pahc-20240630xex32d1.htm (EX-32.1) — 7KB
• pahc-20240630xex32d2.htm (EX-32.2) — 7KB
• pahc-20240630xex97d1.htm (EX-97.1) — 37KB
• pahc-20240630x10k009.jpg (GRAPHIC) — 76KB
• pahc-20240630xex10d25001.jpg (GRAPHIC) — 5KB
• pahc-20240630xex10d25004.jpg (GRAPHIC) — 6KB
• pahc-20240630xex19d1001.jpg (GRAPHIC) — 6KB
• pahc-20240630xex97d1001.jpg (GRAPHIC) — 6KB
• 0001558370-24-012517.txt ( ) — 19223KB
• pahc-20240630.xsd (EX-101.SCH) — 108KB
• pahc-20240630_cal.xml (EX-101.CAL) — 141KB
• pahc-20240630_def.xml (EX-101.DEF) — 389KB
• pahc-20240630_lab.xml (EX-101.LAB) — 778KB
• pahc-20240630_pre.xml (EX-101.PRE) — 796KB
• pahc-20240630x10k_htm.xml (XML) — 3365KB

Forward-Looking Statements and Risk Factors Summary

Forward-Looking Statements and Risk Factors Summary 3 Market Ranking and Other Industry Data 5 Trademarks, Service Marks and Trade Names 5 PART I Item 1.

Business

Business 6 Item 1A.

Risk Factors

Risk Factors 27 Item 1B. Unresolved Staff Comments 52 Item 1C. Cybersecurity 52 Item 2.

Properties

Properties 54 Item 3.

Legal Proceedings

Legal Proceedings 54 Item 4. Mine Safety Disclosures 54 PART II Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 55 Item 6. (Reserved) 56 Item 7.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 56 Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 76 Item 8.

Financial Statements and Supplementary Data

Financial Statements and Supplementary Data 77 Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 116 Item 9A.

Controls and Procedures

Controls and Procedures 116 Item 9B. Other Information 116 Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 116 PART III Item 10. Directors, Executive Officers and Corporate Governance 117 Item 11.

Executive Compensation

Executive Compensation 117 Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 117 Item 13. Certain Relationships and Related Transactions, and Director Independence 117 Item 14. Principal Accountant Fees and Services 117 PART IV Item 15. Exhibits and Financial Statement Schedules 118 Item 16. Form 10-K Summary 122

SIGNATURES

SIGNATURES 123 2 Table of Contents

Forward-Looking Statements and Risk Factors Summary

Forward-Looking Statements and Risk Factors Summary This Annual Report on Form 10-K contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical or current fact included in this report are forward-looking statements. Forward-looking statements discuss our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as "aim," "anticipate," "believe," "estimate," "expect," "forecast," "outlook," "potential," "project," "projection," "plan," "intend," "seek," "may," "could," "would," "will," "should," "can," "can have," "likely," the negatives thereof and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. For example, all statements we make relating to our estimated and projected earnings, revenues, costs, expenditures, cash flows, growth rates and financial results, our plans and objectives for future operations, growth or initiatives, strategies, or the expected outcome or impact of pending or threatened litigation are forward-looking statements. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we expected. Examples of such risks and uncertainties include: outbreaks of animal diseases could significantly reduce demand for our products or availability of raw materials; perceived adverse effects on human health linked to the consumption of food derived from animals that utilize our products could cause a decline in the sales of those products; restrictions on the use of antibacterials in food-producing animals may become more prevalent; the potential Food

Business

Item 1. Business Overview Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise and care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. We market approximately 750 product lines in over 80 countries to approximately 4,200 customers. We develop, manufacture and market a broad range of products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture and dogs. Our products help prevent, control and treat diseases and support nutrition to help improve animal health and well-being. We sell animal health and mineral nutrition products either directly to integrated poultry, swine and cattle producers or through animal feed manufacturers, wholesalers, distributors and veterinarians. Our products include: Animal health products such as antibacterials, anticoccidials, nutritional specialty products, and vaccines and vaccine adjuvants that help improve the animal's health and therefore improve performance, food safety and animal welfare. Our Animal Health segment also includes antibacterials and other processing aids used in the ethanol fermentation industry. Mineral nutrition products that fortify the animal's diet and help maintain optimal health. We have focused our efforts in regions where the majority of livestock production is consolidated in large commercial farms. We believe we are well positioned to grow our sales with our established network of sales, marketing and distribution professionals in markets in North America, Latin America, Asia Pacific, Europe, Africa and the Middle East. We are investing resources to further develop products for the companion animal sector. Our business is currently concentrated in the livestock sector. In addition to animal health and mineral nutrition products, w

View Full Filing

View this 10-K filing on SEC EDGAR